Women Health Devices Market Size By Type (Devices, Consumables), By Product (Surgical, Diagnostic, Contraceptives, Labor & Delivery, Critical Care), By Application (Cancer, Osteoporosis, Infectious Disease, Uterine Fibroids, Post-menopausal Syndrome, Preg

Women Health Devices Market will exceed USD 42.5 billion by 2025; as per a new research report.

Increasing disease burden among women across the globe will propel women health devices market during the forecast period. Rising prevalence of ovarian cancer, especially in women aged 63 years and above will drive the business growth. According to the American Cancer Society, ovarian cancer ranks 5th in cancer demise among women, resulting in more deaths than any other health issue of the female reproductive system. Growing incidence of gynecological cancers coupled with surge in elderly female population across the globe will eventually enhance the demand for advanced diagnostics thereby, augmenting women’s health devices industry growth. Growing elderly women population is also one of the key factors driving demand for women health devices market.

Technological advancements in healthcare industry along with growing demand for minimally invasive procedures will further augment women health devices industry growth during the forthcoming years. Numerous initiatives of health organizations and government pertaining to improvement in women’s health will favor business growth. Additionally, promotion of periodic check-ups for preventive care of women in developing and underdeveloped countries will surge the demand for early disease diagnosis and treatment. Moreover, focus of industry players on R&D activities for development of minimally invasive or non-invasive devices for women health should positively impact industry growth. However, high cost of devices may restrict the business growth to certain extent over the analysis period.

Devices segment is estimated to show around 6.2% CAGR by 2025. Increasing number of women opting for double mastectomies amongst the adult women population will further propel the business growth over forecast timeframe. Adoption of advanced devices to simplify treatment process as per patient requirements will further upsurge segmental growth.

Diagnostic segment held more than 25% revenue share in 2018 and should witness tremendous growth over the coming years. Segment growth is attributed to growing awareness regarding early disease diagnosis that increases the chance of successful treatment in patients. Increasing demand for technologically advanced diagnostic devices such as real-time 4D ultrasound (3DUS, 4DUS) and others to detect symptoms can provide better results and care in patients and thus, will eventually upsurge segment revenue in the foreseeable future.

Uterine fibroids application segment will witness over 6.5% CAGR over the forecast timeframe. According to the U.S. department of health and human services, nearly 20 to 80% of women develop fibroid by the age of 50. Additionally, it is estimated that there are 400,000 new cases of uterine fibroids each year in the U.S, among the women aged above 40. Such factors will accelerate segment growth over the forecast period.

Ambulatory surgical centers segment accounted for more than USD 4 billion in 2018 and is poised to grow over the forecast period. These centers providing cost effective treatments with minimized hospital infection will enhance industry growth. Increasing patient inclination towards ASCs along with rising technological advancements in these centers will further spur the business growth.

Asia Pacific women health devices market is estimated to witness more than 7% CAGR over the forecast period. High growth is attributable to large female patient pool in the region. Awareness among people regarding disease detection and technologically advanced treatment options will favor the regional growth. Improved healthcare services along with rise in government funding for improvement of women health will further augment regional industry growth.

Prominent industry players in the women health devices market include CooperSurgical, Abbott Laboratories, Cardinal Health, F. Hoffmann-La Roche, MedGyn Products, Caldera Medical, GE Healthcare, Koninklijke Philips, Carestream Health, Siemens, Prestige Consumer Healthcare, Hologic and Medline Industries. Key industry players adopt various strategic initiatives that enable them to sustain market competition. For instance, in June 2017, Caldera Medical collaborated with FIUGA Partner. This partnership was undertaken to support uro-gynecological education to minimize women with stress urinary incontinence.